ROCKVILLE, Md.--(BUSINESS WIRE)--Neuralstem, Inc. (NYSE Amex: CUR) today reported that on July 6, it submitted a plan to address Neuralstem’s non-compliance with NYSE Amex listing requirements. Also, on August 7, the Company received notice from the NYSE Amex that it failed to comply with Section (301) of Exchange rules related to its issuance of common stock on June 30. Specifically, the Exchange requires companies to first file an application for the listing of additional securities and receive notice from the Exchange that the securities have been approved for listing. Failure to comply could jeopardize the Company’s continued listing status. However, the Exchange has determined that due to Neuralstem’s current listing status, the Exchange is treating its notice as a Warning Letter pursuant to Section 1009(a)(i) of the Company Guide. The Company has subsequently filed an application with the Exchange seeking approval for the issuance of the additional shares and awaits the Exchange’s decision on the matter. Approval of the application by the Exchange will remedy the deficiency noted in the warning letter.
